|
BPHL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63190000002089E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63891999999111E-05 |
| Normal-vs-Stage2 |
1.41669999997873E-06 |
| Normal-vs-Stage3 |
1.23219999981217E-07 |
| Normal-vs-Stage4 |
6.76639999586115E-08 |
| Stage1-vs-Stage2 |
1.670970E-01 |
| Stage1-vs-Stage3 |
2.448000E-04 |
| Stage1-vs-Stage4 |
2.564700E-03 |
| Stage2-vs-Stage3 |
3.844000E-01 |
| Stage2-vs-Stage4 |
2.807200E-01 |
| Stage3-vs-Stage4 |
5.005600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15640000003725E-06 |
| Normal-vs-AfricanAmerican |
3.78550000013078E-07 |
| Normal-vs-Asian |
3.21290000004915E-06 |
| Caucasian-vs-AfricanAmerican |
6.703600E-03 |
| Caucasian-vs-Asian |
1.777640E-01 |
| AfricanAmerican-vs-Asian |
3.156200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09170000001302E-06 |
| Normal-vs-Female |
3.38730000049026E-07 |
| Male-vs-Female |
1.235660E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.08260000023053E-07 |
| Normal-vs-Extreme_Weight |
1.77459999994856E-06 |
| Normal-vs-Obese |
1.12370000004969E-06 |
| Normal-vs-Extreme_Obese |
2.632100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.004300E-02 |
| Normal_Weight-vs-Obese |
1.163810E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.278250E-01 |
| Extreme_Weight-vs-Obese |
6.706200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.988000E-01 |
| Obese-vs-Extreme_Obese |
2.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.409280E-04 |
| Normal-vs-Age(41-60Yrs) |
1.08300000001282E-06 |
| Normal-vs-Age(61-80Yrs) |
3.07560000001317E-06 |
| Normal-vs-Age(81-100Yrs) |
3.92559999999875E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.823400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.414800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.572000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.453400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.520000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.747600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65931999999147E-05 |
| Normal-VS-Type2 PRCC |
1.50549999999861E-06 |
| Normal-VS-KIRP CIMP |
1.97740002150226E-09 |
| Normal-VS-Unclassified PRCC |
1.02749999997265E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.170300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.54609674957373E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
6.960300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.41280000423671E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
6.962800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.33659999999891E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11589999998818E-06 |
| Normal-vs-N1 |
4.39020000353452E-08 |
| Normal-vs-N2 |
3.02430000043152E-07 |
| N0-vs-N1 |
7.264400E-03 |
| N0-vs-N2 |
8.894000E-02 |
| N1-vs-N2 |
1.519360E-01 |
|
|
